Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016)

References

• Sneader W. Drug prototypes and their exploitation. UK: Wiley; 1996.
   Google Scholar
• Harvey AL. Natural products in drug discovery. Drug Discov Today. 2008;13:894–901.
   PubMed Web of Science ®Google Scholar
• Kashyap D, Tuli HS, Sharma AK. Ursolic acid (UA): a metabolite with promising therapeutic potential. Life Sci. 2016;146:201–213.
   PubMed Web of Science ®Google Scholar
• Silva ML, David JP, Silva LCRC. Bioactive oleanane, lupane and ursane triterpene acid derivatives. Molecules. 2012;17:12197–12205.
   PubMed Web of Science ®Google Scholar
• Shah BA, Qazi GN, Taneja SC. Boswellic acids: a group of medicinally important compounds. Nat Prod Rep. 2009;26:72–89.
   PubMed Web of Science ®Google Scholar
• Hussain H, Al-Harrasi A, Csuk R. Therapeutic potential of boswellic acids: a patent review (1990-2015). Expert Opin Ther Pat. 2017;27:81–90.
   PubMed Web of Science ®Google Scholar
• Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol. 1995;49:57–68.
   PubMed Web of Science ®Google Scholar
• Liu J. Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol. 2005;100:92–94.
   PubMed Web of Science ®Google Scholar
• Jäger S, Trojan H, Kopp T, et al. Pentacyclic triterpene distribution in various plants–rich sources for a new group of multi-potent plant extracts. Molecules. 2009;14:2016−2031.
   PubMed Web of Science ®Google Scholar
• James JT, Dubery IA. Pentacyclic triterpenoids from the medicinal herb, Centella asiatica (L.). Urban Molecules. 2009;14:3922–3941.
   PubMed Web of Science ®Google Scholar
• Wozniak L, Skapska S, Marszałek K. Ursolic acid-a pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules. 2015;20:20614−20641.
   PubMed Web of Science ®Google Scholar
• Murphy BT, MacKinnon SL, Yan X, et al. Identification of triterpene hydroxycinnamates with in vitro anti-tumor activity from whole cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem. 2003;51:3541–3545.
   PubMed Web of Science ®Google Scholar
• Huang HC, Huang CY, Lin-Shiau SY, et al. Ursolic acid inhibits IL-2 beta or TF- alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression. Mol Carcinog. 2009;48:517–531.
   PubMed Web of Science ®Google Scholar
• Shih WL, Yu FL, Chang CD, et al. Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model. Mol Carcinog. 2013;52:800–812.
   PubMed Web of Science ®Google Scholar
• Tian Z, Lin G, Zheng RX, et al. Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneana. World J Gastroenterol. 2006;12:874–879.
   PubMed Web of Science ®Google Scholar
• De Angel RE, Smith SM, Glickman RD, et al. Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer. Nutr Cancer. 2010;62:1074–1086.
   PubMed Web of Science ®Google Scholar
• Kanjoormana M, Kuttan G. Antiangiogenic activity of ursolic acid. Integr Cancer Ther. 2010;9:224–235.
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Manu KA, Ong TH, et al. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int J Cancer. 2011;129:1552–1563.
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Ong TH, Kumar AP, et al. Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. PLoS One. 2012;7:e32476.
   PubMed Web of Science ®Google Scholar
• Ali H, Houghton PJ, Soumyanath A. alpha-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol. 2006;107:449–455.
   PubMed Web of Science ®Google Scholar
• Silva FS, Oliveira PJ, Duarte MF. Oleanolic, ursolic, and betulinic acids as food supplements or pharmaceutical agents for Type 2 diabetes: promise or illusion? J Agric Food Chem. 2016;64:2991–3008.
   PubMed Web of Science ®Google Scholar
• Rao VS, De Melo CL, Queiroz MG, et al. Ursolic acid, a pentacyclic triterpene from Sambucus australis, prevents abdominal adiposity in mice fed a high-fat diet. J Med Food. 2011;14:1375–1382.
   PubMed Web of Science ®Google Scholar
• Rani MP, Raghu KG, Nair MS, et al. Isolation and identification of alpha-glucosidase and protein glycation inhibitors from Stereospermum colais. Appl Biochem Biotechnol. 2014;173:946–956.
   PubMed Web of Science ®Google Scholar
• Wen X, Sun H, Liu J, et al. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies. J Med Chem. 2008;51:3540–3554.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee HI, Seo KI, et al. Effects of ursolic acid on glucose metabolism, the polyol pathway and dyslipidemia in non-obese type 2 diabetic mice. Indian J Exp Biol. 2014;52:683–691.
   PubMed Web of Science ®Google Scholar
• Sundaresan A, Harini R, Pugalendi KV. Ursolic acid and rosiglitazone combination alleviates metabolic syndrome in high fat diet fed C57BL/6J mice. Gen Physiol Biophys. 2012;31:323–333.
   PubMed Web of Science ®Google Scholar
• Jang SM, Kim MJ, Choi MS, et al. Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice. Metab Clin Exp. 2010;59:512–519.
   PubMed Web of Science ®Google Scholar
• Azevedo MF, Camsari C, Sa CM, et al. Ursolic acid and luteolin-7-glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase-3. Phytother Res. 2010;24:S220–224.
   PubMed Web of Science ®Google Scholar
• Jayaprakasam B, Olson LK, Schutzki RE, et al. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J Agric Food Chem. 2006;54:243–248.
   PubMed Web of Science ®Google Scholar
• Chitturi S, George J. Hepatotoxicity of commonly used drugs: nonsteroidal anti- inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid- lowering agents, psychotropic drugs. Semin Liver Dis. 2002;22:169–183.
   PubMed Web of Science ®Google Scholar
• Scheen AJ. Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. Expert Opin Drug Metab Toxicol. 2014;10:839–857.
   PubMed Web of Science ®Google Scholar
• Martin-Aragon S. De Las Heras B, Sanchez-Reus MI. Pharmacological modification of endogenous antioxidant enzymes by ursolic acid on tetrachloride-induced liver damage in rats and primary cultures of rat hepatocytes. J Exp Toxicol Pathol. 2001;53:199–206.
   PubMed Web of Science ®Google Scholar
• Ma JQ, Ding J, Zhang L, et al. Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-kappaB pathway. Environ Toxicol Pharmacol. 2014;37:975–983.
   PubMed Web of Science ®Google Scholar
• Ma JQ, Ding J, Zhang L, et al. Protective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway. Clin Res Hepatol. Gastroenterol. 2015;39:188–197.
   PubMed Web of Science ®Google Scholar
• Lei H, Wang P, Xu K, et al. Triterpene derivative useful in treatment of cancer and its preparation. CN105315321A. 2016.
   Google Scholar
• Li X, Li Y, Xiao X, et al. Application of ursolic acid in producing the medical formulations as antitumor agent for inhibiting liver neoplasm and improving immunity. CN103142620. 2013
   Google Scholar
• Shao J, Tang Q, Liu Y, et al. Ursolic acid-aspirin conjugate compound useful in treatment of cancer and its preparation. CN105111271. 2015.
   Google Scholar
• Shao J, Yang X, Zheng Q, et al. A ursolic acid-glycolysis inhibitor dichloroacetic acid (DCA) conjugate and application. CN104987356. 2015.
   Google Scholar
• Liao X, Gao K, Niu R, et al. Clathrate of ursolic acid and amino cyclodextrin. CN104857003. 2015.
   Google Scholar
• Luan D, Huang W, Luan S, et al. Ursolic acid derivative, preparation method and application. CN104861028. 2015.
   Google Scholar
• Yang B, Wang D, Ma C 3-O-(2-(5-fluorouracil-1-yl)acetyl)ursolic acid useful in treatment of cancer and its preparation. CN104744548. 2015.
   Google Scholar
• Zhang J, Liu Z, Chou G Liquidambaric acid or ursolic acid nano-capsule with improved solubility and good safety and preparation method thereof. CN104721144. 2015.
   Google Scholar
• Gao Y, Li Z, Wang C, et al. Folic acid (FA)-polyamidoamine (PAMAM) dendrimer-ursolic acid (UA) nano medicine with tumor targeting property and good water solubility and bioavailability, and its preparation method by chemical grafting. CN103990145. 2014.
   Google Scholar
• Zhao C, Zhao L Pentacyclic triterpenoid compounds useful in treatment of cancer and their preparation. CN104530172. 2015.
   Google Scholar
• Gu W, Hao Y, Miao T, et al. Ursolic acid indole derivative, preparation method and application. CN104098645. 2014.
   Google Scholar
• Meng Y, Bai J, Bai Z, et al. Ursolic acid chemically modified product with anti-tumor activity and preparation method. CN103626828. 2014.
   Google Scholar
• Zhang D, Gao N, Liu Y, et al. Ursolic acid derivative used in cell proliferation inhibition of human leukemia U937 cells and preparation method. CN103509079. 2014
   Google Scholar
• Yang S, Yang S, Liu M, et al. Ursolic acid ester derivatives, their preparation method and application as anticancer drugs. CN102875632. 2013.
   Google Scholar
• Shao J, Zou W Azacycle containing ursolic acid with antitumor activity and preparation method. CN102675406. 2012
   Google Scholar
• Yang S, Liu M, Yang S, et al. Ursolic acid piperazine amide-like compound, preparation and application. CN102675405. 2012.
   Google Scholar
• Li X, Bai X, Wu K, et al. Preparation of ursolic acid 3ʹ-substituted propanol ester derivatives as anti-tumor. CN102558279. 2012.
   Google Scholar
• Liu Y, Zhang D, Gao N, et al. Ursolic acid derivatives and their preparation method. CN102558282. 2012.
   Google Scholar
• Zhang D, Liu Y, Gao N, et al. Method for preparation of ursolic acid derivatives and medical application. CN102532245. 2012.
   Google Scholar
• Shao J, Wang J Ursolic acid derivative with anticancer activity, their preparation methods and application. CN102516351. 2012.
   Google Scholar
• Shao J, Xiang L, Yang X, et al. Application of ursolic acid derivative in preparation of medicines for preventing and treating tumor metastasis. CN103933048. 2014.
   Google Scholar
• Bai K, Guo Y, Zheng Y, et al. Method for preparation of polyethylene glycol chemically modified ursolic acid derivative with anti-tumor activity. CN102329362. 2012.
   Google Scholar
• Zhang Y, Chen H, Duan Y, et al. Application of 2α,3β,19α-trihydroxy-12-ene-28- ursolic acid in Isodon excisoides in manufacture of antitumor agents. CN106176764A. 2016.
   Google Scholar
• Shao J, Zheng G, Yang X, et al. Metformin conjugate with antitumor and tumor metastasis-resistant activities and preparation. CN106188209A. 2016.
   Google Scholar
• Chen H, Hu J, Chen C, et al. Piperazine modified ursonic acid derivative useful in treatment of cancer and its preparation. CN105693815A. 2016.
   Google Scholar
• Nan F, Xie X, Pei G, et al. Pentacyclic triterpenoid and application for treating Alzheimer’s disease. CN104910238. 2015.
   Google Scholar
• Song X, Tian Z, Zhao T, et al. Application of ursolic acid for treatment of psoriasis. CN105832745A. 2016.
   Google Scholar
• Li J Ursolic acid derivative, preparation method and application as Tryptophan hydroxylase-1 inhibitor for treating osteoporosis. CN103936814. 2014.
   Google Scholar
• Du C, Zhang J, Yu B, Preparation of ursolic acid β-D-glucopyranosyl ester as antiinflammatory agent. CN103739654. 2014
   Google Scholar
• Du C, Zhang J, Yu B, Preparation of 28-O-β-D-glucopyranosyl senegenin as antiinflammatory agent. CN103739655. 2014.
   Google Scholar
• Zhao S, Zhang K, Li D, et al. Ursolic acid derivative as α-glucosidase inhibitor useful in treatment of diabetes mellitus and its preparation. CN104877000. 2015.
   Google Scholar
• Feng X, Chu Z, Wang J, et al. Corosolic acid derivative, and preparing method and application in manufacture of antidiabetic drugs thereof. CN103204894. 2013.
   Google Scholar
• Zhao S, Wu P, Zhang K, et al. hemically modified product of ursolic acid as α-glucosidase inhibitor and its preparation. CN104045678. 2014.
   Google Scholar
• Zhang K, He P, Zhao S, et al. Application of ursolic acid derivative in preparing medicine for preventing, controlling and treating diabetes mellitus. CN103877097. 2014.
   Google Scholar
• Mylari BL, Fleming GA, Ursolic acid salts for treating diabetes and obesity. US20140024708. 2014.
   Google Scholar
• Peng F, Gao Y, He Y Preparation and medicinal application of ursolic acid-berberine salt. CN105801663A. 2016.
   Google Scholar
• Sharma R, Borhade NN, Chakor NS, et al. Preparation of fused triterpene compounds and use as retinoid-related orphan receptors gamma (RORγ) modulators. WO2015198232. 2015.
   Google Scholar
• Xu X, Tian Y, Sun G, et al. 3-Monouronic acid-O-glycoside oleanane type and ursane type triterpene saponin derivatives as antiarrhythmic agents and their preparation. CN105111272. 2015.
   Google Scholar
• Kong L, Li S, Zhang Y, et al. Application of ursolic acid for inhibiting hepatitis C virus infection. CN102908353. 2013
   Google Scholar
• Wen X, Sun H, Jiang L, et al. Pentacyclic triterpenoid enterovirus 71 inhibitor, and pharmaceutical compositions and medical uses thereof. CN104840467. 2015.
   Google Scholar
• Sun H, Chen D, Liu J, et al. Application of pentacyclic triterpene-type compound as squalene oxide cyclase inhibitor. CN104138384. 2014.
   Google Scholar
• Zhao W, Zhang H, Wang H, et al. Caffeoyl-substituted pentacyclic triterpene derivative useful in treatment of various diseases and its preparation. WO2014154131. 2014.
   Google Scholar
• Kazmi I, Afzal M, Anwar F Cardioprotective ursolic acid stearoyl glucoside from leaves of Lantana camara linn. IN2013DE00273. 2014.
   Google Scholar
• Yang X, Huang L, Luo H, et al. Application of trihydroxyl ring A substituted pentacyclic triterpene compound in pharmaceutical or pesticide. CN103919784. 2014.
   Google Scholar
• Eldridge GR, Buckle RN, Ellis M, et al. Preparation of heterocyclic-fused triterpenes as inhibitors of bacterial biofilms and related methods. US8324264. 2012
   Google Scholar
• Liu Y, Xu Q, Li S, et al. Ilex cornuta saponin compound with antioxidant activity, and its preparation method and application. CN103665090. 2015.
   Google Scholar
• Hans J, Grothe T, Woehrle I, et al. Polyhydroxylated pentacyclic triterpene acids as HMG-CoA reductase inhibitors. WO2013171100. 2013
   Google Scholar
• Ting A, Milne JC, Jirousek MR, et al. Fatty acid triterpene derivatives and their uses. WO2012154554. 2012
   Google Scholar
• Xie J, Bai Y, Yi Y Medical application of ursolic acid. CN102631352. 2012.
   Google Scholar
• Sun C, Li Y, Li S et al. Application of ursolic acid in preparing health food for reducing body weight and alleviating fatty liver. CN102512426. 2012.
   Google Scholar
• Kang W, Guo X, Yu Q, et al. Application of ursolic acid in preparation of antithrombotic drugs. CN105708841A. 2016.
   Google Scholar
• Vetal MD, Chavan RS, Rathod VK. Microwave assisted extraction of ursolic acid and oleanolic acid from Ocimum sanctum. Biotechnol. Bioprocess Eng. 2014;9:720–726.
   Web of Science ®Google Scholar
• Zhu Z, Qian Z, Yan Z, et al. A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors. Int J Nanomed. 2013;8:129–136.
   PubMed Web of Science ®Google Scholar
• Wang XH, Zhou SY, Qian ZZ, et al. Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors. Expert Opin Drug Metab Toxicol. 2013;9:117–125.
   PubMed Web of Science ®Google Scholar
• Qian Z, Wang X, Song Z, et al. A phase I trial to evaluate the multiple-dose safety and antitumor activity of ursolic acid liposomes in subjects with advanced solid tumors. Biomed Res Int. 2015:1–7. (Article ID 809714).
   Web of Science ®Google Scholar
• Both DM, Goodtzova K, Yarosh DB, et al. Liposome-encapsulated ursolic acid increases ceramides and collagen in human skin cells. Arch Dermatol Res. 2002;293:569–575.
   PubMed Web of Science ®Google Scholar
• Yarosh DB, Both D, Brown D. Liposomal ursolic acid (merotaine) increases ceramides and collagen in human skin. Horm Res. 2000;54:318–321.
   PubMedGoogle Scholar
• Shao J, Yang X, Xiang L, et al. Amphiphilic polymer nano drug-loaded micelle for improving bioavailability of ursolic acid and structure modification product thereof, and its preparation method by ring opening polymerization. CN103877022A. 2014.
   Google Scholar
• Yao J, Li Y, Zhou J Preparation method of amphiphilic ursolic acid-polysaccharide conjugates and application in cancer therapy. CN103705939A. 2014.
   Google Scholar
• Li X, Zheng D, Zhang H Antitumor application and preparation of ursolic acid drug- delivery nano-microspheres. CN102670525A. 2012.
   Google Scholar
• Shao J, Chi T A dual targeted ursolic acid/siRNA loaded fluorescent mesoporous silica-hyaluronic acid and its application. CN105343895A. 2016.
   Google Scholar
• Kvasnica M, Urban M, Dickinson NJ, et al. Pentacyclic triterpenoids with nitrogen- and sulfur-containing heterocycles: synthesis and medicinal significance. Nat Prod Rep. 2015;32:1303−1330.
   PubMed Web of Science ®Google Scholar
• Man S, Gao W, Zhang Y, et al. Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia. 2010;81:703−714.
   PubMed Web of Science ®Google Scholar